<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">

     <title>RAND Research Topic: Hepatitis C</title>
     <link rel="self" href="http://www.rand.org/topics/hepatitis-c.xml"/>
     <updated>2012-05-24T14:56:48Z</updated>
     <link rel="alternate" type="text/html" hreflang="en" href="http://www.rand.org/topics/hepatitis-c.html" />
     <rights>Copyright (c) 2012, The RAND Corporation</rights>
     <author>
       <name>RAND Corporation</name>
     </author>
     <id>http://www.rand.org/topics/hepatitis-c.html</id>
	 
 <entry>
   <title type="html">Social, Structural and Behavioral Drivers of Concurrent Partnerships Among African American Men in Philadelphia</title>
   <id>http://www.rand.org/pubs/external_publications/EP201100218.html</id>
   <published>Sep 30, 2011</published>
   <updated>Sep 30, 2011</updated>
   <summary type="html">African American men view sexual relationships with non-main partners as riskier; concurrent relationships are acceptable and often expected.</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP201100218.html" />
   
 </entry>
 
 <entry>
   <title type="html">Patient and Provider Characteristics Associated with the Decision of HIV Coinfected Patients to Start Hepatitis C Treatment</title>
   <id>http://www.rand.org/pubs/external_publications/EP201100162.html</id>
   <published>Aug 31, 2011</published>
   <updated>Aug 31, 2011</updated>
   <summary type="html">A patient&apos;s decision to start or defer hepatitis C treatment is influenced by the stage of their disease and by their providers&apos; confidence about the efficacy of hepatitis C treatment.</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP201100162.html" />
   
 </entry>
 
 <entry>
   <title type="html">Substance Use and Other Risk Factors for Unprotected Sex: Results from an Event-Based Study of Homeless Youth</title>
   <id>http://www.rand.org/pubs/external_publications/EP201100199.html</id>
   <published>Dec 31, 2010</published>
   <updated>Dec 31, 2010</updated>
   <summary type="html">This study of condom use among homeless youth in Los Angeles County found that a broad range of individual, relationship, and contexual factors play a role in condom use.</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP201100199.html" />
   
 </entry>
 
 <entry>
   <title type="html">Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion and Sustained Virologic Response in HIV Co-Infected Patients</title>
   <id>http://www.rand.org/pubs/external_publications/EP201100224.html</id>
   <published>Dec 31, 2010</published>
   <updated>Dec 31, 2010</updated>
   <summary type="html">Good mental health may be an indicator of readiness to adhere to treatment for Hepatitis C among individuals who also have HIV.</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP201100224.html" />
   
 </entry>
 
 <entry>
   <title type="html">Pharmacy Participation in Non-Prescription Syringe Sales in Los Angeles and San Francisco Counties, 2007</title>
   <id>http://www.rand.org/pubs/external_publications/EP20100132.html</id>
   <published>Dec 31, 2009</published>
   <updated>Dec 31, 2009</updated>
   <summary type="html">California pharmacies are more likely to participate in a voluntary program allowing limited sale of syringes to adults without a prescription if they think syringe access is important for preventing HIV among drug users.</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20100132.html" />
   
 </entry>
 
 <entry>
   <title type="html">Three Years After Legalization of Nonprescription Pharmacy Syringe Sales in California: Where Are We Now?</title>
   <id>http://www.rand.org/pubs/external_publications/EP20100056.html</id>
   <published>Dec 31, 2009</published>
   <updated>Dec 31, 2009</updated>
   <summary type="html">&lt;p&gt;Many California local health jurisdictions with significant numbers of HIV cases have approved disease prevention demonstration projects, which permit limited sale of syringes to adults without a prescription&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20100056.html" />
   
 </entry>
 
 <entry>
   <title type="html">Treat Early or Wait and Monitor? A Qualitative Analysis of Provider Hepatitis C Virus Treatment Decision-Making in the Context of HIV Coinfection</title>
   <id>http://www.rand.org/pubs/external_publications/EP20090903.html</id>
   <published>Dec 31, 2008</published>
   <updated>Dec 31, 2008</updated>
   <summary type="html">&lt;p&gt;Liver disease is a leading cause of death among patients with HIV coinfected with hepatitis C (HCV); yet, studies show that less than 10% receive HCV treatment, in part because of limited treatment response, high treatment toxicity, and psychosocial barri&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20090903.html" />
   
 </entry>
 
 <entry>
   <title type="html">Human Immunodeficiency Virus and Hepatitis C Virus Testing Services at Syringe Exchange Programs: Availability and Outcomes</title>
   <id>http://www.rand.org/pubs/external_publications/EP20070605.html</id>
   <published>Dec 31, 2006</published>
   <updated>Dec 31, 2006</updated>
   <summary type="html">&lt;p&gt;The authors described the availability and outcomes of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) testing services at syringe exchange programs throughout California, using interviews with 24 syringe exchange program directors and 560 syringe exchange clients. Efforts to increase both the availability of HIV and HCV testing services at syringe exchange programs and the use of existing testing services are needed.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20070605.html" />
   
 </entry>
 
 <entry>
   <title type="html">HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates</title>
   <id>http://www.rand.org/pubs/external_publications/EP20070017.html</id>
   <published>Dec 31, 2006</published>
   <updated>Dec 31, 2006</updated>
   <summary type="html">&lt;p&gt;In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20070017.html" />
   
 </entry>
 
 <entry>
   <title type="html">Impact of Hepatitis C on Health Related Quality of Life: A Systematic Review and Quantitative Assessment</title>
   <id>http://www.rand.org/pubs/external_publications/EP20050419.html</id>
   <published>Dec 31, 2004</published>
   <updated>Dec 31, 2004</updated>
   <summary type="html">&lt;p&gt;Hepatitis C virus (HCV) diminishes health related quality of life (HRQOL), and it is now common to measure HRQOL in clinical trials.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20050419.html" />
   
 </entry>
 
 <entry>
   <title type="html">HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates</title>
   <id>http://www.rand.org/pubs/external_publications/EP20050619.html</id>
   <published>Dec 31, 2004</published>
   <updated>Dec 31, 2004</updated>
   <summary type="html">&lt;p&gt;Study results suggest that integrating HIV and HCV C&amp;T can increase disease screening rates among IDUs. Careful planning of integrated staff activities and schedules is recommended.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20050619.html" />
   
 </entry>
 
 <entry>
   <title type="html">Hepatitis C Virus Treatment Decision-Making in the Context of HIV Co-Infection: The Role of Medical, Behavioral and Mental Health Factors in Assessing Treatment Readiness</title>
   <id>http://www.rand.org/pubs/external_publications/EP20051012.html</id>
   <published>Dec 31, 2004</published>
   <updated>Dec 31, 2004</updated>
   <summary type="html">&lt;p&gt;A greater understanding of the multilevel factors contributing to HCV treatment decision-making, as well as patient characteristics that predict treatment outcome and adherence, can inform the development of interventions aimed at improving HCV care for HIV patients.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20051012.html" />
   
 </entry>
 
 <entry>
   <title type="html">Risk Factors for Hepatitis C Virus Infection Among Homeless Adults</title>
   <id>http://www.rand.org/pubs/external_publications/EP20020209.html</id>
   <published>Dec 31, 2001</published>
   <updated>Dec 31, 2001</updated>
   <summary type="html">&lt;p&gt;Targeted outreach for homeless women and their partners, including HCV testing coupled with referrals to HCV and substance abuse treatments, may be helpful.&lt;/p&gt;</summary>
   <link rel="alternate" type="text/xhtml" hreflang="en" title="Read More" href="http://www.rand.org/pubs/external_publications/EP20020209.html" />
   
 </entry>
 
 </feed>

